Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04051216 · ClinicalTrials.gov registry record · NA
The SMART CART Study: Health Information Technology
A NA study, sponsored by University of Michigan Rogel Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 148
- Enrollment target
NCT04051216 is a NA study that has completed, run by University of Michigan Rogel Cancer Center. The registered enrollment target is 148 participants.
The verdict
NCT04051216, a NA study, has completed, sponsored by University of Michigan Rogel Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 148 participants
- Enrollment target
Study Summary
This study evaluates the feasibility of using two information technology tools in patients undergoing Chimeric Antigen Receptor T-cell (CART) therapy and other Cytokine Release Syndrome (CRS)-eliciting treatments such as CD123 BITE. The first is an Apple iPad® application called the BMT Roadmap, which shows information about the participant's health. The second is a wearable activity monitoring device. Health information technology tools such as Roadmap system and the activity monitoring device may enable caregivers and patients to become more active participants in their healthcare.
Interventions
- OTHER Laboratory Biomarker Analysis
- OTHER Survey Administration
- OTHER Interview
- BEHAVIORAL Education information system
- OTHER Activity monitor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2017-12-20 |
| Est. Completion | 2023-11-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04051216
The ClinicalTrials.gov registry entry for NCT04051216 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan Rogel Cancer Center, which has 292 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Laboratory Biomarker Analysis is the first listed.
NCT04051216 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04051216 about?
NCT04051216 is a clinical study titled "The SMART CART Study: Health Information Technology". This study evaluates the feasibility of using two information technology tools in patients undergoing Chimeric Antigen Receptor T-cell (CART) therapy and other Cytokine Release Syndrome (CRS)-eliciting treatments such as CD123 BITE. The first is an Apple iPad® application called the BMT Roadmap, whi...
What is the current status of trial NCT04051216?
This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2017-12-20. Estimated completion is 2023-11-23.
What interventions are being tested in trial NCT04051216?
The interventions under investigation include: Laboratory Biomarker Analysis (OTHER), Survey Administration (OTHER), Interview (OTHER), Education information system (BEHAVIORAL), Activity monitor (OTHER).
Who is sponsoring clinical trial NCT04051216?
This trial is sponsored by University of Michigan Rogel Cancer Center, which has 292 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.